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Relationship of Conjunctival and Corneal Cal-
cification with Secondary Hyperparathyroidism 
in Hemodialysis Patients 
 
 
 
Abstract 
Background/Objective: Hyperphosphatemia is the consequence of 
end stage renal failure. Inadequate control of serum phosphorus re-
sults in elevated Ca×P product with subsequent soft tissue deposition 
in the form of conjunctival and corneal calcification.  In this study, 
we evaluated the relationship of conjunctival and corneal calcifica-
tion with secondary hyperparathyroidism in hemodialysis patients.  
 
Patients and methods: This is a descriptive–analytic study per-
formed on 24 hemodialysis patients.  We measured serum calcium, 
phosphorus, alkaline phosphatase, iPTH and conjunctival and cor-
neal calcification using slit–lamp microscope according to a modifi-
cation of Porter's criteria. The duration of hemodialysis was 30.7 ± 
21.7 months. 
 
Results: 24 patients participated in this study.  The biochemical val-
ues were: Ca: 9.1 ± 0.8 mg/dl, P: 6.5 ± 2.2 mg/dl, ipTH: 488 ± 326 
pg/ml, Ca×P : 51.5 ± 16.6  
The mean of conjunctival and corneal calcification score was 7.1±4. 
There was a positive correlation between conjunctival and corneal 
calcification with a duration of hemodialysis (p=0.033, r=0.436), 
Ca×P product (p=0.007, r=0.538).  P (p=0.006, r=548) and iPTH (p= 
0.028 , r=0.449).  
There was no correlation between conjunctival and corneal calcifica-
tion with the age of the patients, serum calcium and alkaline phos-
phatase.  
 
Conclusion: There is a positive correlation of serum phosphorus, 
Ca×P product and iPTH with conjunctival and corneal calcification 
and no significant correlation with serum calcium implying that 
there is a central role for phosphorus in calcium-phosphorus deposi-
tion in soft tissues like cornea and conjunctiva, underscoring further 
attention to phosphorus control in hemodialysis patients. 
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Introduction 
 
yperphosphatemia develops invariably 
with kidney failure. Inadequate control of 
serum phosphorus (P) results in an ele-
vated calcium-phosphorus (Ca×P) product, that is 
associated with harmful conditions in chronic renal 
failure, including vascular calcifications, cardiovas-
cular disease and soft tissue depositions.1,2 
In this study we evaluated the relationship between 
the severity of conjunctival and corneal calcification 
with serum calcium (Ca), alkaline phosphatase 
(ALP), phosphorus (P), Ca×P products and intact 
PTH (iPTH). 
 
Subjects and Materials 
 
This is a descriptive–analytic study done on 24 
hemodialysis patients who were on regular hemo-
dialysis 2-3 times per week.  None of the patients 
had any history of malignancy or primary hyper-
parathyroidism and none was taking drugs which 
might affect bone metabolism.  Calcium, phospho-
rus and alkaline phosphatase were measured by 
commercial and standard kits.  iPTH was done by 
DSL-8000 kit (RIA) manufactured in the USA.  The 
hemodialysis adequacy was measured by Urea 
Reduction Rate (URR) formula. The severity of 
conjunctival and corneal calcification was evaluated 
by an opthalmologist who was unaware of lab ex-
ams.  Using slit-lamp microscope calcified deposits 
were classified into the following 6 grades (scores 
0-5) according to a modification of Porter's criteria3 
(Fig 1) O=no deposits, 1=conjuctival deposits only, 
2=conjunctival and strictly limbal deposits, 
3=conjnctival deposits and irregular corneal depos-
its, 4=clear single line of corneal and conjunctival 
deposits, and 5=more extensive corneal deposits 
and conjunctival deposits.  The severity of conjunc-
tival and corneal calcification was determined by 
the total score (0-20 points) obtained at 4 regions 
(nasal and temporal sides of both corneas). The 
data were stratified as mean ± SD, and we used 
frequency distribution for conjunctival and corneal 
calcification together with Pearson Coefficient Test. 
All the data were analyzed by SPSS (version 
11.00) software. 
 
Results 
 
A total of 24 patients participated in this study of 
which males formed 48.8 percent. The mean age 
was 49.7±17.1 and the duration of hemodialysis 
30.7±21.7 months.  The results of biochemical val-
ues were: Ca; 9.1±0.8 mg/dl, P; 6.5±2.2 mg/dl, 
iPTH; 488.1±326 pg/ml (normal 13-54 pg/ml), and 
Ca×P; 51.5±16.6. The mean conjunctival and cor-
neal calcification score was 7.1±4.  The results of 
biochemical parameters and conjunctival and cor-
neal calcification are shown in Table 1.  Table 2, 
shows the frequency distribution of conjunctival and 
corneal calcification.  In this study, there was a 
positive correlation between conjunctival and cor-
neal calcification with duration of hemodialysis 
(Fig1) (P=0.033, r=0.436), Ca×P product (Fig 2) 
(p=0.007, r=0.538), P (Fig 3) (p=0.006, r= 0.548) 
and iPTH (p= 0.028, r=0.449) (Fig 4). 
H 
Table 1: The profile of the age, duration of hemodialysis, and biochemical parameters. 
Results Age 
(years) 
Duration of 
dialysis 
(months) 
iPTH 
(pg/ml) 
Alp 
(IU/lit) 
Ca 
(mg/dl) 
P 
(mg/dl) 
Ca×P URR 
(%) 
Conjunctival &  
corneal calcifica-
tion score 
Mean 49.7 30.7 488.1 431.4 9.1 6.5 51.5 59.4 7.1 
±SD 17.1 21.7 326 234.5 0.8 2.2 16.6 5.6 4 
Max 79 87 1200 1280 11 10 95 70 15 
Min 17 4 25 130 4 3 30 20 2 
 
Table 2: Frequency distribution of conjunctival and 
corneal calcification scores in Patients 
Score Number Percent 
0-3 6 25 
4-7 7 29.2 
8-11 6 25 
12-15 5 20.8 
 
 
 Figure1: Association of corneal and conjunctival  
calcification with duration of hemodialysis 
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There was no correlation between conjunctival and 
corneal calcification with the age of the patients 
(p=0.449, r=-0.162), and also no correlation with 
serum Ca (p=0.809, r= 0.052).  There was not a 
significant correlation between eye scores with Alp. 
(p=0.903, r=-0.02).  
 
Discussion 
 
This study showed a positive correlation between 
conjunctival and corneal calcification with serum 
phosphorus, iPTH, Ca×P-product and duration of 
dialysis.  We could not show a significant correla-
tion between patients’ age, serum calcium and Alp 
with conjunctival and corneal cacification scores.  
Studies concerning the conjunctival and corneal 
calcification during recent years, have shown vari-
able results. In a study by Pahor et al. on 14 hemo-
dialysis patients, a 79% rate of typical conjunctival 
and corneal calcification was found.  This study 
showed that, patients treated longer with hemodi-
alysis, had a higher grade of calcification.4 Similar 
to our study Emmerrich et al. studying 72 dialysis 
patients, showed a statistically significant correla-
tion with the duration of hemodialysis yet no corre-
lation with alkaline phosphatase or the patient's 
age.5 Moreover Vignanelli M et al. showed that 
conjunctival calcification developed in patients suf-
fering from high mathematical product of Ca×PO46 
while Pahor et al. found that product of calcium and 
phosphate and also parathyroid hormone concen-
tration did not differ in patients with or without calci-
fications.  In the study of Emmerich et al., no corre-
lation was found between deposition of calcium 
salts on conjunctiva and Ca×PO4 product.  ِ
Kelenhegyic et al.  working on 27 hemodialysis 
patients elaborated on the role of 
hyperphosphatemia .7  In a recent study by Ta-
kuyama et al, in contrast to our data, no correlation 
was observed between conjuctival and corneal 
calcification and Alp.8  However ,we ,in 
concordance with Takuyama  et al., could not show 
any correlation between serum calcium and 
conjunctival and corneal calcification, implying that 
there ought to be a central role for phosphorus in 
calcium–phosphorus deposition in soft tissues like 
cornea and conjunctiva.  In addition, alkalosis of 
the ocular surface may increase the severity of 
conjunctival and corneal calcification.8,9  Other in-
vestigators have also shown abnormal Ca and P 
values in conjunctival and corneal calcification in 
hemodialysis patients.10-12 Thus, chronic renal fail-
 
Figure 2: Association of corneal and conjunctival 
calcification with Ca × P product 
 
Figure 3: Association of corneal and conjunctival  
calcification  with  serum phosphorus 
 
Figure 4: Association of corneal and conjunctival 
calcification with serum iPTH 
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ure alters the Ca and P balance and results in sec-
ondary hyperparathyroidism.1,13  
The most important problem in hemodialysis pa-
tients is the control of hyperphosphatemia.1,2  Hy-
perphosphatemia has a central role in ectopic calci-
fications caused by an abnormal balance of Ca and 
P metabolism in hemodialysis patients.1   Also It 
seems that a relatively high alkalinity results from 
the diffusion of carbon dioxide (CO2) from the ex-
posed eye surface, which promotes the precipi-
tation of Ca-phosphate salts in high serum Ca×P 
product cases of conjunctival and corneal calcifica-
tion.8-12  Because of improved treatment modalities 
in dialysis therapy, we rarely find patients with se-
vere conjunctival and corneal calcification develop-
ing band keratopathy,12  However, the increased 
frequency of conjunctival and corneal calcification 
in patients undergoing prolonged hemodialysis 
indicates the presence of secondary hyper-
parathroidism and bone metabolic disorder in 
hemodialysis patients, as is also reflected in our 
study.8  In this study, we have underscored the 
serious problem of hyperphosphatemia and secon-
dary hyperparathyroidism in hemodialysis patients.  
In fact, every patient entering dialysis treatment 
should be investigated and counseled by dieticians 
in order to improve nutrition in terms of energy, 
protein and phosphorus intake.1  On a standard 
thrice-weekly dialysis schedule, hyperphos-
phatemia and positive phosphorus balance are 
frequent despite the use of phosphate binders, 
especially in well-nourished patients.1,2,13  As the 
course of conjunctival and corneal calcification can 
be easily followed, the evaluation of the clinical 
courses of conjunctival and corneal calcification is 
very useful for assessing the severity of Ca and P 
imbalance and bone metabolic disorder in hemodi-
alysis patients.8,13   
Further evaluation of the relationship between con-
juctival and corneal calcification and other sites of 
soft tissue calcification like heart and cardiovascu-
lar system appears recomendable. 
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